Retinal Function in Parkinson's Disease



Status:Completed
Conditions:Parkinsons Disease
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 64
Updated:4/2/2016
Start Date:October 2009
End Date:December 2010
Contact:Bruce Ira Gaynes, OD, PharmD
Email:Bruce.Gaynes@va.gov
Phone:708-216-6262

Use our guide to learn which trials are right for you!

Intrinsically Photosensitive Retinal Ganglion Cells in Parkinson's Disease

Parkinson's disease (PD) is a neurodegenerative disorder characterized by muscle rigidity,
tremor, a slowing of physical movement (bradykinesia) and, in extreme cases, a loss of
physical movement. The primary symptoms are the results of decreased stimulation of the
motor cortex arising from the basal ganglia normally caused by the insufficient formation
and action of dopamine, which is produced in the dopaminergic neurons of the brain.
Secondary symptoms may include high level cognitive dysfunction and subtle language
problems. Included in the symptomatology experienced by patients with PD, visual
abnormalities are not uncommon. Visual changes among patients with PD appear not only
dynamic in nature, but differentially affected based on the course of the disease and,
perhaps more importantly, its treatment. Parkinson's disease has significant ramifications
not only in observation of irregularities in vision, but how vision interacts with
entrainment of the circadian clock. The purpose of this study is to examine the relationship
between PD and operation of a unique set of retinal cells known to regulate the circadian
clock and sleep-wake cycles in human subjects.


Inclusion Criteria: age 18-64 best corrected visual acuity of 20/25 or better in each eye
-

Exclusion Criteria: evidence of any form of eye disease, inability to understand and sign
informed consent.
We found this trial at
1
site
Hines, Illinois 60141
?
mi
from
Hines, IL
Click here to add this to my saved trials